You have   6 free profiles   left this month    Start Your Free Trial ➤
Hey, we noticed you're a RelSci Pro subscriber! Would you like to view the page there? View on RelSci Pro ➤

David P. Schenkein

President, Chief Executive Officer & Director at Agios Pharmaceuticals, Inc.
Relationship Science aggregates deep and verified information on over 6 million influential decision makers and the over 1.5 million organizations with which they are associated. From this data, we create a "business social graph" that highlights who knows whom. Here are David P. Schenkein's strongest connections.

People Most Closely Connected to David P. Schenkein

Click the names below to expand relationship details.
John M. Maraganore
Chief Executive Officer at Alnylam Pharmaceuticals, Inc.
Nick Leschly
President & Chief Executive Officer at bluebird bio, Inc.
Robert Tepper
Co-Founder at Third Rock Ventures
Lewis C. Cantley
Founder at Agios Pharmaceuticals, Inc.
Charles L. Sawyers
Chairman, Human Oncology & Pathogenesis Program at Memorial Sloan Kettering Cancer Center
Marc Tessier-Lavigne
President at Stanford University
Ian Clark
Operating Partner at Clarus Ventures
Perry Karsen
Venture Partner at Third Rock Ventures
Alexis Borisy
Partner at Third Rock Ventures
Tak Mak
Founder at Agios Pharmaceuticals, Inc.
Craig B. Thompson
President & Chief Executive Officer at Memorial Sloan Kettering Cancer Center
Mark Levin
Partner at Third Rock Ventures
Ryan J. Watts
Chief Executive Officer & Founder at Denali Therapeutics, Inc.
Robert Taylor Nelsen
Co-Founder at ARCH Venture Partners
Douglas Cole
Co-Founder at Permeon Biologics, Inc.
Kevin P. Starr
Co-Founder at Third Rock Ventures
Xiaodong Wang
Founder at Beigene (Beijing) Co. Ltd.
Troy Cox
Chief Executive Officer & Director at Foundation Medicine, Inc.
There are 3,065 more people accessible only with RelSci Professional.